High-throughput pharmacokinetics screen of VLA-4 antagonists by LC/MS/MS coupled with automated solid-phase extraction sample preparation
- 29 June 2004
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 35 (4) , 867-877
- https://doi.org/10.1016/j.jpba.2004.02.017
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- N-(3-Phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2003
- Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2002
- N-Tetrahydrofuroyl-(l)-phenylalanine derivatives as potent VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2002
- The Discovery of acylated β-Amino acids as potent and orally bioavailable VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2001
- The discovery of sulfonylated dipeptides as Potent VLA-4 antagonistsBioorganic & Medicinal Chemistry Letters, 2001
- Characterization of a technique for rapid pharmacokinetic studies of multiple co-eluting compounds by LC/MS/MSJournal of Pharmaceutical and Biomedical Analysis, 1999
- Peer Reviewed: Sample Preparation for LC/MS/MS: Analyzing Biological and Environmental SamplesAnalytical Chemistry, 1998
- Quantification of a potent 5-HT2a antagonist and an active metabolite in rat plasma and brain microdialysate by liquid chromatography-tandem mass spectrometryJournal of the American Society for Mass Spectrometry, 1997
- The Simultaneous Determination of Mixtures of Drug Candidates by Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as anIn Vivo Drug Screening ProcedureRapid Communications in Mass Spectrometry, 1997
- High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samplesAnalytical Chemistry, 1986